Indications for SARS-CoV-2 nucleic acid amplification test for areas with low endemicity.

Higo, Hisao; Taguchi, Yoshinori; Suzaki, Noriyuki; Nagata, Takuya; Marukawa, Masaomi

Higo, Hisao; Taguchi, Yoshinori; Suzaki, Noriyuki; Nagata, Takuya; Marukawa, Masaomi.

Afiliación

Higo H; Department of Internal Medicine, Kagawa Rosai Hospital, Kagawa, Japan. Electronic address: h_hisao_430@yahoo.co.jp.
Taguchi Y; Department of Internal Medicine, Kagawa Rosai Hospital, Kagawa, Japan.
Suzaki N; Department of Internal Medicine, Kagawa Rosai Hospital, Kagawa, Japan.
Nagata T; Department of Internal Medicine, Kagawa Rosai Hospital, Kagawa, Japan.
Marukawa M; Department of Internal Medicine, Kagawa Rosai Hospital, Kagawa, Japan.

J Infect Chemother ; 28(2): 238-241, 2022 Feb.

Article en En | MEDLINE | ID: mdl-34776347

Asunto(s)

COVID-19; SARS-CoV-2; Prueba de COVID-19; Humanos; Técnicas de Amplificación de Ácido Nucleico; Estudios Retrospectivos

Palabras clave

Coronavirus disease 2019; Gustatory dysfunction; Nucleic acid amplification test; Olfactory dysfunction; Severe acute respiratory syndrome coronavirus 2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google